It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings ...

Eli Lilly and Company (NYSE:LLY – Get Free Report)’s stock price rose 0.1% on Tuesday after Truist Financial raised their price target on the stock from $1,029.00 to $1,038.00. Truist Financial ...

Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...

Eli Lilly and Company discovers ... Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin ...

Six years ago, the average monthly out-of-pocket cost for insulin made by Eli Lilly ... them instead. Lilly, for example, recently revealed that the list price of its Humalog insulin held steady ...

The company has developed notable medications such as Prozac for depression, Humalog for diabetes, and Mounjaro for type 2 diabetes. Looking closer, Eli Lilly and Company has also outpaced the ...

Lower realized prices were primarily driven by Mounjaro, partially offset by Zepbound and Humalog ... Use Of Eli Lilly’s Ulcerative Colitis Drug For Crohn’s Disease The company reported ...

INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE ... partially offset by Zepbound and Humalog. Revenue outside the U.S. increased 55% to $4.50 billion, driven by a 56% ...

and fast-acting insulin Humalog. And that's before we get into the company's pipeline, which features plenty of investigational drugs beyond Eli Lilly's core area of diabetes and obesity.

On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher ... partially offset by Zepbound and Humalog. New Products revenue grew by $3.15 billion to $5.64 billion in Q4 2024, led by ...